We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TVRD
451
Tvardi Therapeutics
TVRD
$23.1M
$23.1M $1.73 1.7%
TCRX icon
452
TScan Therapeutics
TCRX
$22.4M
$22.4M $0.3310 3.02%
CLRB icon
453
Cellectar Biosciences
CLRB
$22.2M
$22.2M $2.35 1.29%
PBM icon
454
Psyence Biomedical
PBM
$22.2M
$22.2M $5.82 4.12%
COCP icon
455
Cocrystal Pharma
COCP
$22M
$22M $1.14 0%
LGVN
456
Longeveron
LGVN
$21.3M
$21.3M $6.68 2.62%
GRDX
457
GridAI Technologies Corp
GRDX
$21M
$21M $2.94 2.65%
NEUP
458
Neuphoria Therapeutics
NEUP
$20.2M
$20.2M $3.74 1.06%
TPST icon
459
Tempest Therapeutics
TPST
$20M
$20M $1.21 60.2%
AKTX
460
Akari Therapeutics
AKTX
$19.7M
$19.7M $10.12 1.27%
NCEL
461
NewcelX Ltd
NCEL
$19.6M
$19.6M $3.39 2.11%
CMMB
462
Chemomab Therapeutics
CMMB
$19.4M
$19.4M $2.65 7.29%
JSPR icon
463
Jasper Therapeutics
JSPR
$19.3M
$19.3M $0.5809 1.89%
MRKR icon
464
Marker Therapeutics
MRKR
$19M
$19M $1.14 2.56%
BCDA icon
465
BioCardia
BCDA
$18.9M
$18.9M $1.25 1.63%
ALLR
466
Allarity Therapeutics
ALLR
$18.5M
$18.5M $1.16 4.5%
LPCN icon
467
Lipocine
LPCN
$17.8M
$17.8M $2.16 1.37%
PTN
468
Palatin Technologies
PTN
$16.8M
$16.8M $9.46 13.5%
KTTA icon
469
Pasithea Therapeutics
KTTA
$16.4M
$16.4M $0.4900 2%
DYAI icon
470
Dyadic International
DYAI
$16.1M
$16.1M $0.4026 5.89%
PASG icon
471
Passage Bio
PASG
$15.6M
$15.6M $4.86 1.89%
CNSY
472
Cerenome
CNSY
$15.5M
$15.5M $2.04 3.77%
CTXR icon
473
Citius Pharmaceuticals
CTXR
$15.4M
$15.4M $0.5600 0.02%
ADIL
474
Adial Pharmaceuticals
ADIL
$15.4M
$15.4M $5.24 4.8%
BIVI icon
475
BioVie
BIVI
$14.7M
$14.7M $1.72 1.71%
17 18
19
20 21

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.29T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $130B, Regeneron Pharmaceuticals (REGN) at $79.7B and argenx (ARGX) at $61.6B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 245 funds opened new positions, taking total fund holders up 179 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.